We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Multiplex Cytokine Assays Need Independent Quality Controls

By HospiMedica staff writers
Posted on 12 Sep 2007
Quality control is particularly important for multiplex cytokine assays due to the greater demands of performing several assays in a single procedure.

Cytokines are signaling proteins, released primarily by immune cells and are implicated in a number of diseases. More...
The complexity of the cytokine signaling network and the roles played by different cytokines is critical to understanding both normal and pathologic processes. There has been an emergence of multiplex assays that give a picture of multiple cytokines in a single sample.

Many cytokine assays suffer from inconsistent accuracy and poor precision. In addition, different manufacturers' assays produce markedly different results depending on the production process and the assay method. Using kit controls can add to the problem. Kit controls are often manufactured using the same materials and production methods as the kit components, then optimized for a specific instrument. They can actually conceal problems arising from the reagents, calibrators, or instruments.

Independent quality controls allow laboratories to validate calibrations, monitor accuracy and precision, and reduce interlaboratory variation. Randox Laboratories (Crumlin, UK) offers tri-level cytokine controls for cytokine assays and high-sensitivity cytokine assays. These controls are suitable for multiplex assays and for multi-center clinical trials.

The Randox controls are 100% human and do not contain preservatives. They are lyophilized and have a two-year shelf life. When reconstituted, they are stable for four hours at +2-8°C or seven days at –20°C. The 12 analytes include seven interleukins (IL-1a, IL-1ß, IL-2, IL-4, IL-6, IL-8, IL-10), epidermal growth factor (EGF), interferon-gamma (IFN-γ), monocyte chemotactic protein-1 (MCP-1), vascular endothelial growth factor (VEGF), and tumor necrosis factor-alpha (TNFa).


Related Links:
Randox Laboratories

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Gas Analyzer
i-Check200
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.